Peptide-peptidase-inhibitor conjugates and methods of making and using same
US8598314B2 · kind B2 · utility
2Cited by
28References
18Claims
0Family size
Assignees
Inventors
Key dates
| Filing date | Sep 26, 2008 |
| Grant date | Dec 3, 2013 |
| Priority date | — |
| Expiry date | Jul 25, 2029 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P9/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Peptide-peptidase inhibitor conjugate molecules and methods of manufacture thereof are disclosed. These conjugate molecules are useful as agents for the treatment and prevention of metabolic and cardiovascular diseases, disorders, and conditions. Such diseases, conditions and disorders include, but are not limited to, hypertension, dyslipidemia, cardiovascular disease, eating disorders, insulin-resistance, obesity, and diabetes mellitus of any kind, and other diabetes-related disorders.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.